| (PLN) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 16.95M | — |
| Operating expense | — | — |
| Net income | -12.65M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RVU.WA returned -37.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -32.1% |
| 1 year | -37.8% |
| 5 years | -69.9% |
| 10 years | +15.0% |
| All-time high | zł 69.40 (Jul 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what zł1,000 in RVU.WA would be worth today ›No. Ryvu Therapeutics S.A. has not paid a dividend in the past 12 months.
Ryvu Therapeutics S.A. is part of the Healthcare sector.
Ryvu Therapeutics S.A. has a market cap of 427.72M PLN, based on the latest quote.
